The CDMO is investing $50m in additional solid-phase peptide synthesis capacity and a new commercial manufacturing line at ...
The new probes advance OGT’s transition of its CytoCell portfolio from IVDD ahead of the December 2028 Class C deadline, ...
New rapid sterility testing capability provides eligible products with results in approximately 3–7 days through automated, ...
VAT relief on free medicines, £1bn in new investment and revised capital allowances give pharma manufacturers progress — but ...
The agreement with the UK Health Security Agency will see the Danish vaccine manufacturer supply its MVA-BN mpox and smallpox ...
Pharmaceutical manufacturers already serialise medicines using 2D codes to meet regulatory requirements, but a 2D code can be so much more than a tick box for compliance, explains Ian Chapman, Strateg ...
A group of biotech founders, big pharma leaders, clinical and CMC specialists, and CDMO executives gathered at a recent ...
The inspection supports renewal of the EU GMP certificate at the company's New Jersey site, which provides pharmaceutical analytical testing, microbiology and development services ...
Specifying synthetic peptides: why the impurity profile, not the purity figure, is the specification
A single HPLC percentage can’t tell two peptide lots apart. A specification that names impurity classes, sets individual ...
Group-wide sustainability score of 86/100 places CordenPharma among the top 5% of companies assessed by EcoVadis in the past ...
Octane Biotech and Currus Biologics automate CUR-001 CAR T-cell manufacturing on the Cocoon platform
Closed, automated process will support Currus’ Phase I trial in mesothelin-positive solid tumours ... with first dosing ...
GmbH has launched mzassist, a vendor-neutral AI and automation control layer for multimodal mass spectrometry data processing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results